R3 Continuum Named One of the Nation’s Best and Brightest

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
37
R3 Continuum Named One of the Nation’s Best and Brightest Companies to Work for in 2018

MINNEAPOLIS, Jan. 22, 2019 (GLOBE NEWSWIRE) -- R3 Continuum (R3) a leader in providing custom behavioral health solutions for workplace well-being announced today they have been selected as a 2018 Best and Brightest Companies to Work For®. To be considered one of the best places to work in the country, it takes more than offering a competitive salary and benefits. It takes an overall commitment to culture, operations, and processes that not only help employees thrive, but that also lead to increased productivity, financial performance, and a positive community impact.

R3 has those winning factors, which is why they have been recognized as one of the 2018 Best and Brightest Companies to Work For® by the National Association for Business Resources (NABR), an organization that shares best practices, tools, and resources to businesses.

R3 is the only behavioral health company to provide custom behavioral health solutions for workplace well-being. With a mission to help organizations of all sizes develop the skills to address these issues, cultivating workplace well-being, safety, and resiliency, R3 credits its success to the dedication of its employees. 

“The R3 Continuum team is made up of exceptional people doing their best to positively impact the world around them. Their dedication to delivering on R3’s commitment of helping organizations cultivate and protect workplace well-being, is evident in our nomination. The company is proud to have incredibly dedicated staff and is happy to empower them to create such a wonderful work environment worthy of the Best and Brightest Award,” said Kevin Hayford, SHRM-SCP, Vice President of Human Resources and Marketing for R3 Continuum.

Participating in NABR’s competition is not for the faint of heart. For more than 20 years, the company has conducted the competition, which involves a thorough vetting of nominees to determine which ones provide outstanding human resource practices and are dedicated to the success of their employees. Organizations are evaluated on categories including communication, work-life balance, employee education, diversity, recognition, and retention and are benchmarked against other regional and national participants, providing a true “Best of Breed” perspective. The process is audited, designed, and scored by market research firm Inquisium.

Winning companies recognize the connection between culture, engaged employees, and corporate financial success. They know that profitability and stability are essential for businesses in today’s economic climate, Jennifer Kluge, NABR’s President and CEO said in a press release announcing the awards. “Companies that recognize that their employees are the key to their success achieve staying power. Our 2018 winners create their human resource standards to ensure employee satisfaction and they set standards for every business to aspire toward,” Kluge said.

“Having a healthy work environment and culture is important to us. We chose to participate in the Best and Brightest nomination process to get an unbiased view of how we are doing in providing that. This award reinforces our efforts and provides us third-party validation that our work environment is employee-focused, and our employees enjoy working here,” said Kevin Hayford.

While being named one of the best companies in the nation is certainly an honor for R3 and its employees, company President, Jim Mortensen adds that receiving this distinction also demonstrates the strength of experience and skill R3 offers to its clients.

“The nature of our work involves our employees interacting with people and situations that are very sensitive, highly impactful, and can be profoundly personal. Our employees have to be professional and unbiased in their approach to the situation while simultaneously being empathetic and supportive to the individual. To do that consistently, day in and day out, requires us to have a healthy and supportive culture. In order to cultivate and protect the well-being of others, we start by cultivating and protecting the well-being of our employees,” said Jim Mortensen, President of R3 Continuum.

To learn more about R3 or this recognition, please visit our website ( R3c.com ) or contact us directly at 866-927-0184.

About the Best and Brightest Programs The Best and Brightest Companies to Work For® competition identifies and honors organizations that display a commitment to excellence in operations and employee enrichment that lead to increased productivity and financial performance. This competition scores potential winners based on regional data of company performance and a set standard across the nation. This national program celebrates those companies that are making better business, creating richer lives and building a stronger community as a whole. Visit www.thebestandbrightest.com to learn more.

About R3 Continuum R3 Continuum (R3) is the only behavioral health company to provide custom behavioral health solutions for workplace well-being. We offer tailored evaluations, crisis response, consulting solutions, and more to help organizations and employees cultivate resilience and productivity, enabling both to thrive.

Media Contact: Jamie Gassmann Marketing Manager 952-641-0636 Jamie.gassmann@R3c.com  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading